Notes

Clinicopathological and also genomic functions in individuals together with head and neck neuroendocrine carcinoma.
Despite the availability of guidelines for the management of chronic myeloid leukaemia (CML), various issues may prevent their successful implementation. The TARGET survey examined real-world management of CML patients compared with international recommendations. This online survey was completed in 2017. Results were discussed by a Steering Committee (SC) of eight international haematologists, challenges were identified and practical solutions developed. Of the 1008 haematologists invited (33 countries), 614 completed the survey. Gaps regarding treatment efficacy and molecular monitoring were identified. Half of the physicians did not perform three-monthly testing of during the initial 12 months of treatment, citing cost as the major barrier, although they know it should be done. Treatment-free remission was not considered a primary treatment goal or as a priority factor influencing treatment decisions. European Leukemia Net guidelines interpretation was generally acceptable, but awareness regarding management of persistent adverse events was poor. Practical solutions proposed by the SC were mostly focused on enhancing physician education and awareness, or encouraging hospitals to work with the government, in order to improve the quality of BCR-ABL testing. Gaps in current CML management were identified compared with international recommendations, which the proposed practical solutions would help to address. © 2020 British Society for Haematology and John Wiley & Sons Ltd.WHAT IS KNOWN AND OBJECTIVE Esomeprazole, the S-isomer of omeprazole, is a proton pump inhibitor which has been approved by over 125 countries, also known as NEXIUM® . Esomeprazole was developed to provide further improvement on efficacy for acid-related diseases with higher systemic bioavailability due to the less first-pass metabolism and lower plasma clearance. Esomeprazole is primarily metabolized by CYP2C19. Approximately less then 1% of Caucasians and 5%-10% of Asians have absent CYP2C19 enzyme activity. Although the influence of various CYP2C19 phenotypes on esomeprazole pharmacokinetics has been studied, this is the first report in the Japanese population where 27 low CYP2C19 metabolizers were included. METHODS In this study, a population PK model describing the PK of esomeprazole was developed to understand the difference of CYP2C19 phenotypes on clearance in the Japanese population. The model quantitatively assessed the influence of CYP2C19 phenotype on esomeprazole PK in healthy Japanese male subjects after receiving repeated oral dosing. The inhibition mechanism of esomeprazole on CYP2C19 activity was also included in the model. RESULTS AND DISCUSSION CYP2C19 phenotype and dose were found as statistically significant covariates on esomeprazole clearance. The apparent clearance at 10-mg dose was 17.32, 9.77 and 7.37 (L/h) for homozygous extensive metabolizer, heterozygous extensive metabolizer and poor metabolizer subjects, respectively. And the apparent clearance decreased as dose increased. WHAT IS NEW AND CONCLUSION The established population PK model well described the esomeprazole PK and model-predicted esomeprazole PK was in good agreement with external clinical data, suggesting the robustness and applicability of the current model for predicting esomeprazole PK. © 2020 John Wiley & Sons Ltd.in English, Spanish La mortalidad de los animales en las carreteras es una amenaza muy importante para las poblaciones silvestres y se pronostica que aumentarán enérgicamente debido a la construcción continua y planeada de carreteras. Si estas nuevas carreteras no pueden evitarse, se necesitarán medidas efectivas de mitigación para detener la declinación de la biodiversidad. El cercado a lo largo de las carreteras reduce efectivamente los atropellamientos y se usa frecuentemente junto con los pasos de fauna. Ya que cercar por completo la carretera no siempre es posible debido a las restricciones financieras, es común identificar las áreas con una frecuencia alta de atropellamientos para que la colocación de cercas esté informada al respecto. Diseñamos un plan adaptativo de implementación de cercas para priorizar las secciones de carretera que requieren ser cercadas. En este marco de trabajo, identificamos las áreas a lo largo de las carreteras con un nivel alto, moderado y bajo de mortalidad animal (respectivalidad. Sin embargo, muchas cercas bajas pueden ser menos efectivas en la práctica debido al efecto de valla (es decir, que los animales se muevan alrededor de la cerca con mayor facilidad), lo que resulta en una compensación entre pocas cercas altas y muchas cercas bajas, que denominamos compensación de cercas FLOMS (pocas-altas-o-muchas-bajas). check details Los umbrales en las gráficas de reducción de la mortalidad se presentaron para algunos patrones de atropellamiento, pero no para otros. Los umbrales pueden ser útiles para considerar cuando se determinan los objetivos de mitigación para las carreteras. La existencia de los umbrales a escalas múltiples y la compensación de FLOMS tienen implicaciones importantes para la conservación de la biodiversidad. Un Plan Adaptativo para la Priorización de Secciones de Carretera para Cercar y Reducir la Mortalidad Animal.OBJECTIVES To characterize the cumulative risk factors of social and behavioral determinants of health (SDoH) and examine their association with self-rated general health, functional limitations, and use of health services among US older adults. DESIGN Cross-sectional analysis of the 2013-2014 National Health and Nutrition Examination Survey. SETTING Nationally representative health interview survey in the United States. PARTICIPANTS Survey respondents aged 65 or older (n = 1,306 unweighted). MEASUREMENTS A cumulative risk score of SDoH, developed by the National Academy of Medicine expert panel, was assessed using validated measures. Outcome variables included self-rated general health, functional limitations (eg, activities of daily living), and use of health services (eg, usual source of care and overnight hospitalization). We quantified the cumulative risk score of SDoH in older adults and used multivariable-adjusted logistic and Poisson regression analyses to assess the association of SDoH with self-rated health, functional limitations, and use of health services, adjusting for other covariates.
Homepage: https://www.selleckchem.com/products/sc-43.html